Thompson Davis & Co., Inc. Homology Medicines, Inc. Transaction History

Thompson Davis & Co., Inc.

  • $153 Million
  • Q4 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2018

Nov 14, 2018
SELL
$15.54 - $22.86 $1,554 - $2,286
-100 Closed
0 $0
Q2 2018

Aug 03, 2018
BUY
$16.49 - $21.55 $1,648 - $2,155
100 New
100 $2,000

Others Institutions Holding FIXX

# of Institutions
3
Shares Held
66.2K
Call Options Held
0
Put Options Held
0
View Full List

About Homology Medicines, Inc.

FIXX Quotes by TradingView
  • Ticker FIXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 57,402,000
  • Description
  • Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...
More about FIXX
Track This Portfolio

Track Thompson Davis & Co., Inc. Portfolio

Follow Thompson Davis & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thompson Davis & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on Thompson Davis & Co., Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email